FX5, a non-steroidal glucocorticoid receptor antagonist, ameliorates diabetic cognitive impairment in mice.

Authors:
Zhu DY; Lu J; Xu R; Yang JZ; Meng XR and 9 more

Journal:
Acta Pharmacol Sin

Publication Year: 2022

DOI:
10.1038/s41401-022-00884-9

PMCID:
PMC9525278

PMID:
35260821

Journal Information

Full Title: Acta Pharmacol Sin

Abbreviation: Acta Pharmacol Sin

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interests."

Evidence found in paper:

"This work was supported by Innovative Research Team of Six Talent Peaks Project in Jiangsu Province (grant number TD-SWYY-013), the National Natural Science Foundation for Young Scientists of China (grant number 81703806), the Natural Science Foundation for Young Scientists of Nanjing University of Chinese Medicine (grant number NZY81703806), the Open Project of Chinese Materia Medica First-Class Discipline of Nanjing University of Chinese Medicine (grant number 2020YLXK018), and Postgraduate Research & Practice Innovation Program of Jiangsu Province (grant number KYCX21_1737)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025